Trials / Completed
CompletedNCT01618266
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 375 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Epidemiological study of Ozurdex® in sites treating patients with retinal vein occlusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexamethasone intravitreal implant | dexamethasone intravitreal implant 700 μg administered into the eye according to physician judgment. |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-04-01
- Completion
- 2014-10-01
- First posted
- 2012-06-13
- Last updated
- 2016-03-14
- Results posted
- 2016-02-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01618266. Inclusion in this directory is not an endorsement.